Advertisement
Screener

CUBIST PHARMACEUTICALS INC Interest Expense

CUBIST PHARMACEUTICALS INC Interest Expense

CUBIST PHARMACEUTICALS INC reported Interest Expense of $14.66 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2014-11-07

  • CUBIST PHARMACEUTICALS INC interest expense for the quarter ending 2014-09-30 was $14.66M, a 64.32% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC interest expense for the quarter ending 2014-06-30 was $14.51M, a 100.11% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC interest expense for the quarter ending 2014-03-31 was $14.39M, a 100.38% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC interest expense for the quarter ending 2013-12-31 was $14.24M, a 91.12% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC interest expense for fiscal 2013 was $37.60M, a 13.98% increase from fiscal 2012.
  • CUBIST PHARMACEUTICALS INC interest expense for fiscal 2012 was $32.99M, a 5.02% increase from fiscal 2011.
  • CUBIST PHARMACEUTICALS INC interest expense for fiscal 2011 was $31.41M, a 22.81% increase from fiscal 2010.
  • CUBIST PHARMACEUTICALS INC interest expense for fiscal 2010 was $25.58M, a 22.45% increase from fiscal 2009.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 9 monthInterest Expense 12 month
2014-09-30$14.66M
10-Q · filed 2014-11-07
$29.17M
derived: sum of 2 quarters · filed 2014-11-07
$43.57M
10-Q · filed 2014-11-07
$57.81M
derived: sum of 4 quarters · filed 2014-11-07
2014-06-30$14.51M
10-Q · filed 2014-08-11
$28.90M
10-Q · filed 2014-08-11
$43.15M
derived: sum of 3 quarters · filed 2014-08-11
$52.07M
derived: sum of 4 quarters · filed 2014-11-07
2014-03-31$14.39M
10-Q · filed 2014-05-02
$28.64M
derived: sum of 2 quarters · filed 2014-05-02
$37.56M
derived: sum of 3 quarters · filed 2014-11-07
$44.81M
derived: sum of 4 quarters · filed 2014-11-07
2013-12-31$14.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$23.17M
derived: sum of 2 quarters · filed 2014-11-07
$30.42M
derived: sum of 3 quarters · filed 2014-11-07
$37.60M
10-K · filed 2014-02-25
2013-09-30$8.92M
10-Q · filed 2014-11-07
$16.17M
derived: sum of 2 quarters · filed 2014-11-07
$23.36M
10-Q · filed 2014-11-07
$30.81M
derived: sum of 4 quarters · filed 2014-11-07
2013-06-30$7.25M
10-Q · filed 2014-08-11
$14.43M
10-Q · filed 2014-08-11
$21.89M
derived: sum of 3 quarters · filed 2014-08-11
$29.52M
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$7.18M
10-Q · filed 2014-05-02
$14.64M
derived: sum of 2 quarters · filed 2014-05-02
$22.27M
derived: sum of 3 quarters · filed 2014-05-02
$31.17M
derived: sum of 4 quarters · filed 2014-05-02
2012-12-31$7.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$15.08M
derived: sum of 2 quarters · filed 2014-02-25
$23.98M
derived: sum of 3 quarters · filed 2014-02-25
$32.99M
10-K · filed 2014-02-25
2012-09-30$7.63M
10-Q · filed 2013-11-12
$16.53M
derived: sum of 2 quarters · filed 2013-11-12
$25.54M
10-Q · filed 2013-11-12
$33.37M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$8.90M
10-Q · filed 2013-08-06
$17.91M
10-Q · filed 2013-08-06
$25.74M
derived: sum of 3 quarters · filed 2014-02-25
$33.62M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31$9.01M
10-Q · filed 2013-05-07
$16.84M
derived: sum of 2 quarters · filed 2014-02-25
$24.71M
derived: sum of 3 quarters · filed 2014-02-25
$32.47M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$7.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$15.71M
derived: sum of 2 quarters · filed 2014-02-25
$23.46M
derived: sum of 3 quarters · filed 2014-02-25
$31.41M
10-K · filed 2014-02-25
2011-09-30$7.88M
10-Q · filed 2012-11-05
$15.63M
derived: sum of 2 quarters · filed 2012-11-05
$23.59M
10-Q · filed 2012-11-05
$32.79M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-30$7.75M
10-Q · filed 2012-08-07
$15.71M
10-Q · filed 2012-08-07
$24.91M
derived: sum of 3 quarters · filed 2013-02-27
$30.44M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-31$7.95M
10-Q · filed 2012-05-01
$17.15M
derived: sum of 2 quarters · filed 2013-02-27
$22.69M
derived: sum of 3 quarters · filed 2013-02-27
$28.15M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-31$9.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$14.73M
derived: sum of 2 quarters · filed 2013-02-27
$20.19M
derived: sum of 3 quarters · filed 2013-02-27
$25.58M
10-K · filed 2013-02-27
2010-09-30$5.53M
10-Q · filed 2011-11-02
$10.99M
derived: sum of 2 quarters · filed 2011-11-02
$16.38M
10-Q · filed 2011-11-02
$21.69M
derived: sum of 4 quarters · filed 2012-02-27
2010-06-30$5.46M
10-Q · filed 2011-07-29
$10.85M
10-Q · filed 2011-07-29
$16.16M
derived: sum of 3 quarters · filed 2012-02-27
$21.45M
derived: sum of 4 quarters · filed 2012-02-27
2010-03-31$5.39M
10-Q · filed 2011-04-29
$10.70M
derived: sum of 2 quarters · filed 2012-02-27
$15.99M
derived: sum of 3 quarters · filed 2012-02-27
$21.17M
derived: sum of 4 quarters · filed 2012-02-27
2009-12-31$5.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
$10.61M
derived: sum of 2 quarters · filed 2012-02-27
$15.78M
derived: sum of 3 quarters · filed 2012-02-27
$20.89M
10-K · filed 2012-02-27
2009-09-30$5.29M
10-Q · filed 2010-10-29
$10.47M
derived: sum of 2 quarters · filed 2010-10-29
$15.58M
10-Q · filed 2010-10-29
2009-06-30$5.17M
10-Q · filed 2010-07-30
$10.28M
10-Q · filed 2010-07-30
2008-12-31$21.07M
10-K · filed 2011-02-23